Literature DB >> 34586124

Development and application of ultrasound contrast agents in biomedicine.

Yu Wang1, Hailin Cong1,2, Song Wang1, Bing Yu1,2, Youqing Shen1,3.   

Abstract

With the rapid development of molecular imaging, ultrasound (US) medicine has evolved from traditional imaging diagnosis to integrated diagnosis and treatment at the molecular level. Ultrasound contrast agents (UCAs) play a crucial role in the integration of US diagnosis and treatment. As the micro-bubbles (MBs) in UCAs can enhance the cavitation effect and promote the biological effect of US, UCAs have also been studied in the fields of US thrombolysis, mediated gene transfer, drug delivery, and high intensity focused US. The application range of UCAs is expanding, and the value of their applications is improving. This paper reviews the development and application of UCAs in biomedicine in recent years, and the existing problems and prospects are pointed out.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34586124     DOI: 10.1039/d1tb00850a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  3 in total

1.  Biosynthetic Gas Vesicles from Halobacteria NRC-1: A Potential Ultrasound Contrast Agent for Tumor Imaging.

Authors:  Mingjie Wei; Manlin Lai; Jiaqi Zhang; Xiaoqing Pei; Fei Yan
Journal:  Pharmaceutics       Date:  2022-06-03       Impact factor: 6.525

Review 2.  Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment.

Authors:  Rajneesh Mungur; Jiesheng Zheng; Ben Wang; Xinhua Chen; Renya Zhan; Ying Tong
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 3.  Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges.

Authors:  Xiao Hu; Yu-Sen Zhang; Yi-Chao Liu; Na Wang; Xian-Tao Zeng; Ling-Ling Zhang
Journal:  J Nanobiotechnology       Date:  2022-10-04       Impact factor: 9.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.